Silencing of activin receptor-like kinase 7 alleviates aortic stiffness in type 2 diabetic rats

Acta Diabetologica

Volumn 52, Issue 4, 2015, Pages 717-726

  Li, Wen bo ^a   Zhao, Jing ^a   Liu, Lin ^a   Wang, Zhi hao ^a   Han, Lu ^a   Zhong, Ming ^a   Zhang, Yun ^a   Zhang, Wei ^a   Tang, Meng xiong ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

ALK7; Aortic stiffness; Diabetes; Smad2 3; Vascular

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 7; CHOLESTEROL; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GLUCOSE; SHORT HAIRPIN RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ACTIVIN RECEPTOR 1; ACVR1C PROTEIN, RAT; SMALL INTERFERING RNA; STREPTOZOCIN;

ALK7 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL STIFFNESS; ARTICLE; CHEMICAL PARAMETERS; CHOLESTEROL BLOOD LEVEL; COLLAGEN FIBER; COLLAGEN I TO COLLAGEN III RATIO; CONTROLLED STUDY; ELASTIC FIBER; ELASTIN TO COLLAGEN RATIO; GENE OVEREXPRESSION; GENE SILENCING; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; COMPLICATION; DIABETIC ANGIOPATHY; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENETICS; LIPID DIET; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RNA INTERFERENCE; SPRAGUE DAWLEY RAT; TRANSGENIC RAT;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIET, HIGH-FAT; HYPERLIPIDEMIAS; INSULIN RESISTANCE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; STREPTOZOCIN; VASCULAR STIFFNESS;

EID: 84937787142     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-014-0706-8     Document Type: Article

References (32)

1. Bozorgmanesh M, Hadaegh F, Azizi F (2010) Transportability of the updated diabetes prediction model from Atherosclerosis Risk in Communities Study to a Middle Eastern adult population: community-based cohort study. Acta Diabetol 50(2):175–181. doi:10.1007/s00592-010-0241-1
2. Law B, Fowlkes V, Goldsmith JG, Carver W, Goldsmith EC (2012) Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function. Microsc Microanal 18(1):22–34. doi:10.1017/s1431927611012256
3. Srikanth S, Deedwania P (2011) Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus. Cardiol Clin 29(1):47–70. doi:10.1016/j.ccl.2010.11.004
4. Salminen M, Kuoppamäki M, Vahlberg T, Räihä I, Irjala K, Kivelä S-L (2011) Metabolic syndrome and vascular risk: a 9-year follow-up among the aged in Finland. Acta Diabetol 48(2):157–165. doi:10.1007/s00592-010-0251-z
5. Sesti G, Andreozzi F, Fiorentino TV, Mannino GC, Sciacqua A, Marini MA, Perticone F (2014) High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. Acta Diabetol 51(5):705–713. doi:10.1007/s00592-014-0576-0
6. Tauzin L (2014) Alterations in viscoelastic properties following premature birth may lead to hypertension and cardiovascular disease development in later life. Acta Paediatr. doi:10.1111/apa.12815
7. Tang A, Eng JJ, Brasher PM, Madden KM, Mohammadi A, Krassioukov AV, Tsang TS (2014) Physical activity correlates with arterial stiffness in community-dwelling individuals with stroke. J Stroke Cerebrovasc Dis 23(2):259–266. doi:10.1016/j.jstrokecerebrovasdis.2013.01.020
8. Miyamoto M, Kotani K, Okada K, Fujii Y, Konno K, Ishibashi S, Taniguchi N (2011) The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitus. Acta Diabetol 49(1):63–68. doi:10.1007/s00592-011-0287-8
9. Jung C-H, Lee W-Y, Kim S-Y, Jung J-H, Rhee E-J, Park C-Y, Mok J-O, Oh K-W, Kim C-H, Park S-W, Kim S-W (2009) The relationship between coronary artery calcification score, plasma osteoprotegerin level and arterial stiffness in asymptomatic type 2 DM. Acta Diabetol 47(S1):145–152. doi:10.1007/s00592-009-0154-z
10. Xu J (1842) Shi GP (2014) Vascular wall extracellular matrix proteins and vascular diseases. Biochim Biophys Acta 11:2106–2119. doi:10.1016/j.bbadis.2014.07.008
11. Lan TH, Huang XQ, Tan HM (2013) Vascular fibrosis in atherosclerosis. Cardiovasc Pathol 22(5):401–407. doi:10.1016/j.carpath.2013.01.003
12. Li L, Fan D, Wang C, Wang JY, Cui XB, Wu D, Zhou Y, Wu LL (2011) Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-beta1 pathways in cardiac fibroblasts. Cardiovasc Res 91(1):80–89. doi:10.1093/cvr/cvr067
13. Kamato D, Burch ML, Piva TJ, Rezaei HB, Rostam MA, Xu S, Zheng W, Little PJ, Osman N (2013) Transforming growth factor-beta signalling: role and consequences of Smad linker region phosphorylation. Cell Signal 25(10):2017–2024. doi:10.1016/j.cellsig.2013.06.001
14. Ryden M, Imamura T, Jornvall H, Belluardo N, Neveu I, Trupp M, Okadome T, ten Dijke P, Ibanez CF (1996) A novel type I receptor serine-threonine kinase predominantly expressed in the adult central nervous system. J Biol Chem 271(48):30603–30609
15. Zhao F, Huang F, Tang M, Li X, Zhang N, Amfilochiadis A, Li Y, Hu R, Jin T, Peng C, Wang Q (2012) Nodal induces apoptosis through activation of the ALK7 signaling pathway in pancreatic INS-1 beta-cells. Am J Physiol Endocrinol Metab 303(1):E132–E143. doi:10.1152/ajpendo.00074.2012
16. Bertolino P, Holmberg R, Reissmann E, Andersson O, Berggren PO, Ibanez CF (2008) Activin B receptor ALK7 is a negative regulator of pancreatic beta-cell function. Proc Natl Acad Sci USA 105(20):7246–7251. doi:10.1073/pnas.0801285105
17. Andersson O, Korach-Andre M, Reissmann E, Ibanez CF, Bertolino P (2008) Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity. Proc Natl Acad Sci USA 105(20):7252–7256. doi:10.1073/pnas.0800272105
18. Liu L, Ding WY, Zhao J, Wang ZH, Zhong M, Zhang W, Chen YG, Zhang Y, Li L, Tang MX (2013) Activin receptor-like kinase 7 mediates high glucose-induced H9c2 cardiomyoblast apoptosis through activation of Smad2/3. Int J Biochem Cell Biol 45(9):2027–2035. doi:10.1016/j.biocel.2013.06.018
19. Shen N, Lin H, Wu T, Wang D, Wang W, Xie H, Zhang J, Feng Z (2013) Inhibition of TGF-beta1-receptor posttranslational core fucosylation attenuates rat renal interstitial fibrosis. Kidney Int 84(1):64–77. doi:10.1038/ki.2013.82
20. Carlsson LMS, Jacobson P, Walley A, Froguel P, Sjöström L, Svensson P-A, Sjöholm K (2009) ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease. Biochem Biophys Res Commun 382(2):309–314. doi:10.1016/j.bbrc.2009.03.014
21. Zhang W, Wang H, Lv R, Wang Z, Shang Y, Zhang Y, Zhong M, Chen Y, Tang M (2013) ALK7 gene polymorphism is associated with metabolic syndrome risk and cardiovascular remodeling. Arq Bras Cardiol 101(2):134–140. doi:10.5935/abc.20130148
22. Ti Y, Xie GL, Wang ZH, Bi XL, Ding WY, Wang J, Jiang GH, Bu PL, Zhang Y, Zhong M, Zhang W (2011) TRB3 gene silencing alleviates diabetic cardiomyopathy in a type 2 diabetic rat model. Diabetes 60(11):2963–2974. doi:10.2337/db11-0549
23. Stehouwer CD, Henry RM, Ferreira I (2008) Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 51(4):527–539. doi:10.1007/s00125-007-0918-3
24. Salum E, Butlin M, Kals J, Zilmer M, Eha J, Avolio AP, Arend A, Aunapuu M, Kampus P (2014) Angiotensin II receptor blocker telmisartan attenuates aortic stiffening and remodelling in STZ-diabetic rats. Diabetol Metab Syndr 6:57. doi:10.1186/1758-5996-6-57
25. Pyeritz RE (2014) Heritable thoracic aortic disorders. Curr Opin Cardiol 29(1):97–102. doi:10.1097/hco.0000000000000023
26. Yogosawa S, Izumi T (2013) Roles of activin receptor-like kinase 7 signaling and its target, peroxisome proliferator-activated receptor gamma, in lean and obese adipocytes. Adipocyte 2(4):246–250. doi:10.4161/adip.24974
27. Yogosawa S, Mizutani S, Ogawa Y, Izumi T (2013) Activin receptor-like kinase 7 suppresses lipolysis to accumulate fat in obesity through downregulation of peroxisome proliferator-activated receptor gamma and C/EBPalpha. Diabetes 62(1):115–123. doi:10.2337/db12-0295
28. Byfield SDC, Major C, Laping NJ, Roberts AB (2004) SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol 65(3):744–752. doi:10.1124/mol.65.3.744
29. Akpan I, Goncalves MD, Dhir R, Yin X, Pistilli EE, Bogdanovich S, Khurana TS, Ucran J, Lachey J, Ahima RS (2009) The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity. Int J Obes 33(11):1265–1273. doi:10.1038/ijo.2009.162
30. Mita T, Watada H, Shimizu T, Tamura Y, Sato F, Watanabe T, Choi JB, Hirose T, Tanaka Y, Kawamori R (2007) Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control. Arterioscler Thromb Vasc Biol 27(11):2456–2462. doi:10.1161/atvbaha.107.152835
31. Searls Y, Smirnova IV, Vanhoose L, Fegley B, Loganathan R, Stehno-Bittel L (2012) Time-dependent alterations in rat macrovessels with type 1 diabetes. Exp Diabetes Res 2012:278620. doi:10.1155/2012/278620
32. Agabiti-Rosei E, Porteri E, Rizzoni D (2009) Arterial stiffness, hypertension, and rational use of nebivolol. Vasc Health Risk Manag 5(1):353–360